Analysis of the Glutathione Cycle in Children With Rett Syndrome
Withdrawn
- Conditions
- Rett Syndrome
- Registration Number
- NCT02360436
- Lead Sponsor
- Edison Pharmaceuticals Inc
- Brief Summary
Analyis of the Glutathione Cycle in Children with Rett Syndrome
- Detailed Description
To analyze the levels of glutathione and relevant glutathione metabolites in children with Rett syndrome in an effort to better understand disease pathology and biochemistry.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Age between 2 and 10, inclusive
- Genetically-confirmed diagnosis of Rett syndrome with MeCP2 mutation
- No change in dietary supplements in three months prior to the initial blood draw
- No participation in interventional pharmaceutical clinical trials in prior 12 months
Exclusion Criteria
- None other than meeting Inclusion criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analysis of changes in levels of glutathione and relevant glutathione metabolites in children with Rett syndrome from baseline to the end of month 6 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Alabama, Birmingham
🇺🇸Birmingham, Alabama, United States